Antimicrobial Triclosan-coated Sutures Market Share Driven by Rising Post-Surgical Infection Control Measures | Valuates Reports

Antimicrobial Triclosan-coated Sutures - Market Size
The global market for Antimicrobial Triclosan-coated Sutures was estimated to be worth US$ 223 million in 2023 and is forecast to a readjusted size of US$ 514.2 million by 2030 with a CAGR of 12.4% during the forecast period 2024-2030

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-36H8621/Global_Antimicrobial_Triclosan_coated_Sutures_Market_Insights_Forecast_to_2028

The antimicrobial triclosan-coated sutures market is witnessing notable market growth as healthcare systems globally intensify efforts to prevent surgical site infections (SSIs) and improve postoperative outcomes. Increasing awareness of hospital-acquired infections and the clinical benefits of antimicrobial sutures are key market trends expanding the market size. These sutures are becoming a preferred choice in surgical procedures due to their ability to inhibit bacterial colonization and reduce complications without altering standard wound healing processes.

Among the product types, polyglactin 910 sutures currently hold the largest market share, attributed to their superior handling, tensile strength, and biodegradability. These sutures offer consistent antimicrobial protection and are widely adopted across general surgery, gynecology, and orthopedic procedures. Other material sutures are showing the fastest market growth, as manufacturers explore alternative bioabsorbable and synthetic options to meet evolving clinical needs and material performance expectations.

In terms of application, hospitals dominate the market, driven by the high volume of surgical procedures, stringent infection control protocols, and increased procurement of infection-preventive medical devices. At the same time, clinics are emerging as the fastest-growing application segment, supported by the growing shift toward outpatient surgeries and same-day procedures where infection control remains critical. Both settings continue to integrate triclosan-coated sutures to support improved patient safety standards.

The market forecast is optimistic, underpinned by ongoing clinical studies validating the efficacy of antimicrobial sutures, increased regulatory approvals, and rising adoption in both developed and emerging healthcare systems. As surgical volumes rise and infection prevention becomes a global priority, antimicrobial triclosan-coated sutures are expected to play a vital role in enhancing surgical care outcomes and sustaining long-term market growth.

Segment by Type:

• Polyglactin 910 Suture
• Other Material Sutures

Segment by Application

• Hospital
• Clinic

By Company

Johnson & Johnson (Ethicon), Dolphin Sutures, Lotus Surgicals, The Healthium Group, Internacional Farmacéutica, Meril Life Sciences, Unilene

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-36H8621/global-antimicrobial-triclosan-coated-sutures

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.